HABIB BANK LIMITED Imatinib Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Imatinib from India and how much does HABIB BANK LIMITED import?

India exports Imatinib to 456 buyers globally worth $8.8M. HABIB BANK LIMITED imports $800.0K (2.6% market share) with 16 shipments from PAKISTAN.

Q: What is the average order value for HABIB BANK LIMITED's Imatinib imports?

HABIB BANK LIMITED's average Imatinib order value is $50.0K per consignment, based on 16 shipments totaling $800.0K.

Q: Who supplies Imatinib to HABIB BANK LIMITED?

HABIB BANK LIMITED sources Imatinib from 1 verified supplier: CIPLA LIMITED ($800.0K, 100.0%). Based on 16 customs records.

Q: How does HABIB BANK LIMITED compare to other Imatinib importers?

HABIB BANK LIMITED ranks #6 among 456 Imatinib importers from India with 2.6% market share and 16 shipments.

Q: Who are the top Imatinib importers from India?

Top Imatinib importers: AUROLOGISTICS LLC, (AUROBINDO PHARM ($1.5M), JS BANK LTD. ($850.0K), COOPER PHARMA ($800.0K), HABIB BANK LIMITED ($750.0K), AUROBINDO PHARMA USA INC ($700.0K).

Suresh Sormare

Imatinib

India Pharmaceutical Trade Intelligence

$29.3M224 Suppliers119 CountriesHS 30049049

ExportsIndia → UNITED STATES24.3%India → BELGIUM12.4%

ImportsGERMANY → India$331.7M UNITED STATES → India$584.7K

#1 Supplier: CIPLA LIMITED #1 Buyer: H.ESSERS &

HABIB BANK LIMITED — Imatinib Importer #6 | $800.0K Trade Value | TransData Nexus | TransData Nexus

HABIB BANK LIMITED — Imatinib Importer Profile

Pharmaceutical Importer · #6 buyer for Imatinib · $800.0K import value · 16 shipments · PAKISTAN · DGFT Verified

HABIB BANK LIMITED is the #6 importer of Imatinib from India with $800.0K in import value and 16 verified shipments. HABIB BANK LIMITED holds a 2.6% market share in Imatinib imports based in PAKISTAN. The company sources from 1 verified supplier across 14 formulations shipped to 1 country. Overall, HABIB BANK LIMITED imports 3 pharmaceutical products worth $1.3M across 2 therapeutic categories.

HABIB BANK LIMITED — Imatinib Import Profile: Suppliers, Formulations & Sources

HABIB BANK LIMITED — Imatinib import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Imatinib to HABIB BANK LIMITED?

Verified from 16 customs shipment records

Supplier	Value	Shipments	% Share
CIPLA LIMITED	$800.0K	16	100.0%

HABIB BANK LIMITED sources Imatinib from 1 verified Indian supplier based on 16 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.

How Does HABIB BANK LIMITED Compare to Nearest Imatinib Importers?

Buyers ranked immediately above and below #6 by import value

#	Buyer	Country

Where Does HABIB BANK LIMITED Import Imatinib To?

Destination countries from 16 verified shipments

Country	Value	Shipments	Share
PAKISTAN	$800.0K	16	100.0%

HABIB BANK LIMITED imports Imatinib to 1 country. The primary destination is PAKISTAN receiving 100.0% of shipments worth $800.0K.

What Imatinib Formulations Does HABIB BANK LIMITED Import?

Formulation	Value	Shipments
IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG )(1X10'S X 60120 PACKS =601200 NOS)NOS	$150.0K	3
IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG )(1 X 10'S X 23,580 PACK=235800 NOS)	$50.0K	1
IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG )(1 X 10'S X 23,390 PACK=233900 NOS)	$50.0K	1
IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG )(1 X 10'SX61,710 PACK=617100 NOS)	$50.0K	1
IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG ) (INV.QTY.23780 PACK 1X10S=237800 NOS)	$50.0K	1
IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG ) (INV.QTY.61350 PACK 1X10S=613500 NOS)	$50.0K	1
IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG ) (INV.QTY.23660 PACK 1X10S=236600 NOS)	$50.0K	1
IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG ) (INV.QTY.23290 PACK 1X10S=232900 NOS)	$50.0K	1
IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG ) (INV.QTY.23320 PACK 1X10S=233200 NOS)	$50.0K	1
IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG ) (INV.QTY.22960 PACK 1X10S=229600 NOS)	$50.0K	1

HABIB BANK LIMITED imports 14 distinct Imatinib formulations from India. The top formulation is IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG )(1X10' with 3 shipments worth $150.0K.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Imatinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: HABIB BANK LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as HABIB BANK LIMITED's capped import value divided by total capped export value for Imatinib across all Indian exporters.
5.Verified Records: This page is backed by 16 individual customs records matching HABIB BANK LIMITED importing Imatinib, covering 14 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 119+ countries, 456+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Imatinib

Imatinib

HABIB BANK LIMITED — Imatinib Importer Profile

HABIB BANK LIMITED — Imatinib Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Imatinib to HABIB BANK LIMITED?

How Does HABIB BANK LIMITED Compare to Nearest Imatinib Importers?

Where Does HABIB BANK LIMITED Import Imatinib To?

What Imatinib Formulations Does HABIB BANK LIMITED Import?

Who Are the Top Buyers of Imatinib from India and How Much Does HABIB BANK LIMITED Import?

What Is the Average Order Value for HABIB BANK LIMITED's Imatinib Imports?

Who Supplies Imatinib to HABIB BANK LIMITED?

How Does HABIB BANK LIMITED Compare to Other Imatinib Importers?

What Other Advanced Oncology Products Does HABIB BANK LIMITED Import?

About HABIB BANK LIMITED

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Imatinib Import Data for HABIB BANK LIMITED

HABIB BANK LIMITED × Imatinib

Company Overview

Top Products by HABIB BANK LIMITED

Related Analysis

Need Detailed Import Data?

Data Source

7	JS BANK LTD.	PAKISTAN	$850.0K	17	$50.0K
2	COOPER PHARMA	MOROCCO	$800.0K	16	$50.0K
6	HABIB BANK LIMITED ★	PAKISTAN	$750.0K	15	$50.0K
4	AUROBINDO PHARMA USA INC	UNITED STATES	$700.0K	14	$50.0K
8	AUROBINDO PHARMA USA., INC,	UNITED STATES	$650.0K	13	$50.0K